Crossmark

Prognostic Value of Tumor-Infiltrating Lymphocyte Density Assessed Using a Standardized Method Based on Molecular Subtypes and Adjuvant Chemotherapy in Invasive Breast Cancer

Crossref DOI link: https://doi.org/10.1245/s10434-017-6332-2

Published Online: 2018-01-12

Published Print: 2018-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Jang, Nuri

Kwon, Hee Jung

Park, Min Hui

Kang, Su Hwan

Bae, Young Kyung
Funding

Funding for this research was provided by:

Medical Research Center Program through the National Research Foundation of Korea (NRF), Ministry of Science, ICT and Future Planning (2015R1A5A2009124)
License Information

Text and Data Mining valid from 2018-01-12
More Information

Article History

Received: 31 October 2017

First Online: 12 January 2018

Document is current

Any future updates will be listed below